Related Experiment Video

Updated: Dec 10, 2025

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

180

Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer

Siddhartha Devarakonda1, Ramaswamy Govindan1, Daniel Morgensztern1

  • 1Alvin Siteman Cancer Center at Washington University, Washington University School of Medicine, 660 S Euclid Box 8056, St. Louis, MO, USA.

Cancer Cell
|August 29, 2020
PubMed

Insights

The National Lung Matrix trial assigned personalized therapies to patients with non-small cell lung cancer (NSCLC) based on a 28-gene next-generation sequencing panel. This study explored targeted treatment strategies for advanced NSCLC.

Area of Science:

  • Oncology
  • Genomics
  • Clinical Trials

Background:

  • Non-small cell lung cancer (NSCLC) is a leading cause of cancer death.
  • Personalized medicine aims to tailor treatments to individual patient profiles.
  • Genomic profiling is crucial for identifying actionable mutations in NSCLC.

Purpose of the Study:

  • To report the results of the National Lung Matrix trial.
  • To evaluate the efficacy of personalized therapy in previously treated NSCLC patients.
  • To assess the utility of a 28-gene next-generation sequencing panel for treatment assignment.

Main Methods:

  • Patients with previously treated NSCLC were enrolled.
  • A 28-gene next-generation sequencing (NGS) panel was used for genomic analysis.
  • Patients were assigned to personalized therapy based on NGS results.

Main Results:

  • The study reports on the outcomes of personalized treatment strategies.
  • Genomic alterations identified by the NGS panel informed therapeutic choices.
  • Treatment assignment was directly linked to the molecular profile of the tumors.

Conclusions:

  • Personalized therapy guided by genomic profiling shows promise in NSCLC.
  • The 28-gene NGS panel is a viable tool for identifying therapeutic targets.
  • The National Lung Matrix trial provides valuable data on precision oncology in NSCLC.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K